Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma

Figure 7

Pyroptosis-related prognostic signature correlated with TMB, MSI, and drug sensitivity in LUSC. (a) The correlation between pyroptosis-related prognostic signature and TMB. (b) The correlation between pyroptosis-related prognostic signature and MSI. (c) The correlation between pyroptosis-related prognostic signature and drug IC50 of CTRP. TMB: tumor mutation burden; MSI: microsatellite instability; CTRP: cancer therapeutics response portal.

(a)

(b)

(c)